• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Estimation of fusel-oil in spirits
  Analyst, 1890,15, 203-209
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acids

Introduction to 4-2-(Boc-amino)ethyloxybenzoic Acid (CAS No. 168892-66-8)

4-2-(Boc-amino)ethyloxybenzoic Acid, identified by its Chemical Abstracts Service (CAS) number 168892-66-8, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the class of benzoic acid derivatives, characterized by its unique structural motif that combines a benzene ring with an ethyloxy group and a Boc (tert-butoxycarbonyl)-protected amino group. Such structural features make it a versatile intermediate in the synthesis of more complex molecules, particularly in the development of novel therapeutic agents.

The significance of 4-2-(Boc-amino)ethyloxybenzoic Acid lies in its potential applications as a building block for drug discovery. The presence of both an amino group and an ethyloxy substituent on the benzoic acid core provides multiple points of modification, allowing chemists to tailor its properties for specific biological targets. In recent years, there has been a growing interest in benzoic acid derivatives due to their demonstrated efficacy in various pharmacological contexts, including anti-inflammatory, analgesic, and antimicrobial activities.

One of the most compelling aspects of 4-2-(Boc-amino)ethyloxybenzoic Acid is its role in the synthesis of peptidomimetics and protein-protein interaction inhibitors. The Boc-amino group serves as a protective group for the amine functionality, allowing for selective reactions at other positions on the molecule. This protection-deprotection strategy is crucial in multi-step synthetic routes where functional groups need to be manipulated with high precision. Furthermore, the ethyloxy side chain introduces a hydrophilic element, which can influence solubility and metabolic stability—key factors in drug design.

Recent advancements in computational chemistry have enhanced the ability to predict the biological activity of compounds like 4-2-(Boc-amino)ethyloxybenzoic Acid. Molecular docking studies have shown that this compound can interact with various enzymes and receptors, suggesting potential therapeutic applications. For instance, research indicates that derivatives of benzoic acid may inhibit cyclooxygenase (COX) enzymes, which are implicated in inflammation and pain pathways. The Boc-amino group can be later removed under specific conditions to reveal a free amine, which can then be further functionalized to create more complex pharmacophores.

The synthesis of 4-2-(Boc-amino)ethyloxybenzoic Acid typically involves multi-step organic transformations, starting from commercially available aromatic precursors. Key steps include etherification to introduce the ethyloxy group, followed by selective protection of the amino function with Boc chloride. The choice of solvents and reaction conditions is critical to ensure high yield and purity. Modern synthetic techniques, such as flow chemistry and microwave-assisted reactions, have been explored to improve efficiency and scalability.

In the realm of medicinal chemistry, 4-2-(Boc-amino)ethyloxybenzoic Acid has been utilized as a scaffold for designing molecules with improved pharmacokinetic profiles. The benzoic acid moiety is known for its ability to enhance binding affinity through π-stacking interactions with biological targets. By modifying substituents like the ethyloxy group, chemists can fine-tune these interactions while maintaining overall molecular integrity. This flexibility has led to several promising candidates entering preclinical development pipelines.

One notable application of 4-2-(Boc-amino)ethyloxybenzoic Acid is in the development of kinase inhibitors. Kinases are enzymes that play a central role in cell signaling pathways and are often targeted in cancer therapy. The structural features of this compound allow it to mimic natural substrates or compete with ATP binding sites on kinase domains. Preliminary studies have shown that certain analogs derived from 4-2-(Boc-amino)ethyloxybenzoic Acid exhibit inhibitory activity against specific kinases, making them valuable starting points for further optimization.

The Boc-protection strategy is particularly advantageous when dealing with sensitive functional groups that might otherwise undergo unwanted side reactions during synthesis or purification. Once the Boc group is removed under mild acidic conditions, the resulting free amine can be coupled to other fragments via amide bond formation—a common strategy in peptide and drug synthesis. This modular approach allows for rapid diversification of molecular structures while maintaining control over key pharmacophoric elements.

From an industrial perspective, 4-2-(Boc-amino)ethyloxybenzoic Acid represents an important intermediate for large-scale production processes. Its stability under storage conditions makes it suitable for commercial distribution as a raw material for research laboratories and pharmaceutical manufacturers alike. As demand for custom synthetic intermediates grows, compounds like this one are likely to become even more integral to drug discovery initiatives worldwide.

The integration of machine learning tools into virtual screening has accelerated the identification of novel hits based on structural fragments like those found in 4-2-(Boc-amino)ethyloxybenzoic Acid. By leveraging large datasets containing known bioactive molecules along with their corresponding activities against biological targets, computational models can predict new derivatives with enhanced potency or selectivity before experimental validation becomes necessary—a significant time-saving measure given today’s high-throughput screening capabilities.

In conclusion,4-2-(Boc-amino)ethyloxybenzoic Acid (CAS No., 168892-66-8) stands out as a versatile chemical entity with broad utility across multiple disciplines within chemical biology and pharmaceutical science Its unique structural attributes provide chemists with ample opportunities not only optimize existing treatments but also develop entirely new therapeutic strategies targeting some most pressing human diseases

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)